Harvard Bioscience buy Benchmark Co.
Start price
10.03.23
/
50%
€2.60
Target price
10.03.24
€3.77
Performance (%)
51.54%
End price
11.03.24
€3.94
Summary
This prediction ended on 11.03.24 with a price of €3.94. The BUY prediction by Benchmark_Co_ for Harvard Bioscience saw massive gains of 51.54%. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Harvard Bioscience | - | - | - | - |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % | 53,61 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % | 72,78 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % | 62,43 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % | 60,74 % |
Comments by Benchmark_Co_ for this prediction
In the thread Harvard Bioscience diskutieren
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for HBIO provided by MarketBeat
In the thread Trading Harvard Bioscience
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten

